Soon after I published a post on the mention of precision medicine in President Barack Obama’s January 28, 2015 State of the Union address, The White House released additional information on their initiative.
This guide analyzes how artificial intelligence – including machine learning – can be used by pharmaceutical and medical device companies to improve the clinical data review and cleansing process.
The President’s 2016 Budget is set to allocate $215 million to the National Institutes of Health (NIH), Food and Drug Administration (FDA), and the Office of the National Coordinator for Health Information Technology (ONC) for a variety of research and development efforts:
Here’s how the $215 million breaks down:
- $130 million to NIH for development of a voluntary national research cohort of a million or more volunteers to propel our understanding of health and disease and set the foundation for a new way of doing research through engaged participants and open, responsible data sharing.
- $70 million to the National Cancer Institute (NCI), part of NIH, to scale up efforts to identify genomic drivers in cancer and apply that knowledge in the development of more effective approaches to cancer treatment.
- $10 million to FDA to acquire additional expertise and advance the development of high quality, curated databases to support the regulatory structure needed to advance innovation in precision medicine and protect public health.
- $5 million to ONC to support the development of interoperability standards and requirements that address privacy and enable secure exchange of data across systems.
To read the objectives of the precision medicine initiative, click here.
If you’re interested in or in the process of instituting a precision medicine program at your organization, consider registering for Oracle Industry Connect, a free event geared towards executives, from March 25-26. The healthcare track specifically will feature discussions around precision medicine with leaders from the industry.
To learn how Perficient’s helping other organizations enable precision medicine, contact us.